Reboot biomedical R&D in the global public interest
Published on: Wednesday 09 February 2022
Inequitable access to the fruits of research during the COVID-19 pandemic highlights the urgency — and feasibility — of overhauling the R&D system. Inequitable access to the fruits of research during the COVID-19 pandemic highlights the urgency — and feasibility — of overhauling the R&D system.
News source: https://www.nature.com/articles/d41586-022-00324-y
